298 related articles for article (PubMed ID: 17605650)
1. Percutaneous coronary intervention and the no-reflow phenomenon.
van Gaal WJ; Banning AP
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Suryapranata H; Stone GW; Antoniucci D; Neumann FJ; Chiariello M
Am Heart J; 2007 Mar; 153(3):343-53. PubMed ID: 17307410
[TBL] [Abstract][Full Text] [Related]
3. No-reflow phenomenon and prognosis in patients with acute myocardial infarction.
Ito H
Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):499-506. PubMed ID: 16932767
[TBL] [Abstract][Full Text] [Related]
4. "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention.
Fischell TA; Subraya RG; Ashraf K; Perry B; Haller S
J Invasive Cardiol; 2007 Feb; 19(2):58-62. PubMed ID: 17268038
[TBL] [Abstract][Full Text] [Related]
5. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction].
Yang YJ; Zhao JL
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176
[No Abstract] [Full Text] [Related]
6. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
Alfayoumi F; Srinivasan V; Geller M; Gradman A
Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
[TBL] [Abstract][Full Text] [Related]
7. Mechanical thrombectomy options in complex percutaneous coronary interventions.
Kelly RV; Cohen MG; Stouffer GA
Catheter Cardiovasc Interv; 2006 Dec; 68(6):917-28. PubMed ID: 17086518
[TBL] [Abstract][Full Text] [Related]
8. No reflow phenomenon in coronary heart disease.
Ito H
J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
[TBL] [Abstract][Full Text] [Related]
10. Epicardial and microvascular reperfusion with primary percutaneous coronary intervention.
Bolognese L; Falsini G; Liistro F; Angioli P; Ducci K
Ital Heart J; 2005 Jun; 6(6):447-52. PubMed ID: 16008148
[TBL] [Abstract][Full Text] [Related]
11. Distal vessel pullback angiography and pressure gradient measurement: an innovative diagnostic approach to evaluate the no-reflow phenomenon.
Sherman JR; Anwar A; Bret JR; Schreibfeder MM
Cathet Cardiovasc Diagn; 1996 Sep; 39(1):1-6. PubMed ID: 8874936
[TBL] [Abstract][Full Text] [Related]
12. Treatment of saphenous vein graft thrombosis with distal protection, thrombectomy, and adenosine prior to reperfusion: a complete approach to preserving microvascular integrity.
St John M; Heldman AW
J Invasive Cardiol; 2004 Jun; 16(6):336-8. PubMed ID: 15156007
[TBL] [Abstract][Full Text] [Related]
13. Rotational coronary atherectomy in acute ST-segment elevation myocardial infarction.
Ho PC
J Interv Cardiol; 2005 Aug; 18(4):315-8. PubMed ID: 16115167
[TBL] [Abstract][Full Text] [Related]
14. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion.
Reffelmann T; Kloner RA
Basic Res Cardiol; 2006 Sep; 101(5):359-72. PubMed ID: 16915531
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.
Michaels AD; Appleby M; Otten MH; Dauterman K; Ports TA; Chou TM; Gibson CM
J Invasive Cardiol; 2002 Jun; 14(6):299-302. PubMed ID: 12042618
[TBL] [Abstract][Full Text] [Related]
16. Features and outcome of no-reflow after percutaneous coronary intervention.
Abbo KM; Dooris M; Glazier S; O'Neill WW; Byrd D; Grines CL; Safian RD
Am J Cardiol; 1995 Apr; 75(12):778-82. PubMed ID: 7717278
[TBL] [Abstract][Full Text] [Related]
17. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.
Fischell T; Haller S; Ashraf K
J Invasive Cardiol; 2005 Jun; 17(6):334-7. PubMed ID: 16003012
[No Abstract] [Full Text] [Related]
18. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.
Moens AL; Claeys MJ; Timmermans JP; Vrints CJ
Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623
[TBL] [Abstract][Full Text] [Related]
19. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Lerman A; Holmes DR; Herrmann J; Gersh BJ
Eur Heart J; 2007 Apr; 28(7):788-97. PubMed ID: 17347176
[TBL] [Abstract][Full Text] [Related]
20. The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.
Harding SA
Heart; 2006 Sep; 92(9):1191-3. PubMed ID: 16606861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
